From Christiane Wolf-Schwerin
-----------------
Dear Thomas,
Stefan Schreiber and Philip Rosenstiel will be attending the DDW in Chicago, May 6 - 10. They asked me to announce that they will not be able to attend the teleconference therefore.
With best regards,
Christiane
Dr. Christiane Wolf-Schwerin
Personal Assistant to Prof. Schreiber
University Hospital Schleswig-Holstein
Institute for Clinical Molecular Biology
Schittenhelmstr. 12
24105 Kiel, Germany
phone: +49 (0)431/597-2350
fax: +49 (0)431/597-1434
From: geuvadis_rnaseq-bounces@lists.crg.es [mailto:geuvadis_rnaseq-bounces@lists.crg.es] On Behalf Of Ralf Sudbrak
Sent: jueves, 28 de abril de 2011 17:14
To: geuvadis_rnaseq@lists.crg.es
Subject: Re: [Geuvadis_rnaseq] Geuvadis RNAseq TC details
Dear Thomas,
as my vote in the doodle poll indicated, I am not available at the 6th of May, but I trust the consortium that the scientifically best approach will be chosen. Until the 13.5. I am traveling and might have only limited email access.
Best wishes
Ralf
On 26.04.2011 11:27, Thomas Giger wrote:
Dear All,
thank you for having filled in the doodle.
The Geuvadis RNAseq phone conference will take place on May 6 from 11am - 12pm CEST.
To participate in this call you have to do the following:
- if you call in from Switzerland dial: +41 58 262 07 22
- otherwise from other countries please find enclosed the list with the "local access numbers for teleconferences" and dial the number corresponding to your country.
Then enter the PIN: 611683
In case you need assistance during the call - dial "OO" (nil nil) to get in touch with an operator.
I have written down the following points that should be discussed:
1. As of now we made plans that the different labs analyze samples from one particular population (as listed in the workflow document that I've sent around on April 7).
It would be a better experimental design if the samples were randomly distributed among the different labs. Since there is still time to react - do we want to switch the strategy?
2. How long are the library prep / sequencer queue up times in the different labs (once you receive the RNA samples - how long do you think will it take you to analyze them?).
If some labs expect to have much larger delays, we could make arrangements that those labs get samples earlier than other labs.
This would also mean that we would all use the protocol that is used at the time point when the first lab starts to analyze samples.
3. Which other samples (other than the 500 1KGP European samples) should be analyzed by RNAseq?
4. Specifications for the small RNA protocol.
If you already know now, that you would like to have additional things discussed - please let me know and I can make sure that we don't forget about.
Looking forward to talk to you soon,
Thomas
=
------------------------------------------------------------------------
Thomas Giger, Ph.D.
Department of Genetic Medicine and Development
University of Geneva Medical School
1 Rue Michel-Servet
Geneva 1211
Switzerland